Search research articles
Contact Us
Filters
Showing results (31-40 of 72) with videos related to
Page
of 8
Sort By:
Cancer Research
|
November 1, 1970
Phase specificity of 5-azacytidine against mammalian cells in tissue culture
L H Li, E J Olin, T J Fraser, et al.
Cancer Research
|
January 1, 1981
Cell kill kinetics of several nogalamycin analogs and adriamycin for Chinese hamster ovary, L1210 leukemia, and B16 melanoma cells in culture
B K Bhuyan, C L Blowers, S L Crampton, et al.
Experimental Cell Research
|
February 1, 1976
Comparison of different methods of determining cell viability after exposure to cytotoxic compounds
B K Bhuyan, B E Loughman, T J Fraser, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1993
Cell kill kinetics and cell cycle effects of taxol on human and hamster ovarian cell lines
N M Lopes, E G Adams, T W Pitts, et al.
Investigational New Drugs
|
January 1, 1987
Drug sensitivity of ten human tumor cell lines compared to mouse leukemia (L1210) cells
G J Badiner, R D Hamilton, L H Li, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1995
Synergistic and additive combinations of several antitumor drugs and other agents with the potent alkylating agent adozelesin
K S Smith, B A Folz, E G Adams, et al.
Cancer Research
|
March 1, 1976
Combination chemotherapy of L1210 leukemia with 1-beta-D-arabinofuranosylcytosine and 5-azacytidine
G L Neil, A E Berger, B K Bhuyan, et al.
The Journal of Antibiotics
|
June 1, 1977
Cytotoxicity of several marketed antibiotics on mammalian cells in culture
L H Li, S L Kuentzel, K D Shugars, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1997
Assessment of microtubule stabilizers by semiautomated in vitro microtubule protein polymerization and mitotic block assays
N M Lopes, H P Miller, N D Young, et al.
Cancer Research
|
January 1, 1988
Mutagenicity of the antitumor antibiotic CC-1065 and its analogues in mammalian (V79) cells and bacteria
P R Harbach, D M Zimmer, J H Mazurek, et al.
Page
of 8
Search research articles
Search
Showing results (31-40 of 72) with videos related to
Sort By:
Page
of 8
Cancer Research
|
November 1, 1970
Phase specificity of 5-azacytidine against mammalian cells in tissue culture
L H Li, E J Olin, T J Fraser, et al.
Cancer Research
|
January 1, 1981
Cell kill kinetics of several nogalamycin analogs and adriamycin for Chinese hamster ovary, L1210 leukemia, and B16 melanoma cells in culture
B K Bhuyan, C L Blowers, S L Crampton, et al.
Experimental Cell Research
|
February 1, 1976
Comparison of different methods of determining cell viability after exposure to cytotoxic compounds
B K Bhuyan, B E Loughman, T J Fraser, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1993
Cell kill kinetics and cell cycle effects of taxol on human and hamster ovarian cell lines
N M Lopes, E G Adams, T W Pitts, et al.
Investigational New Drugs
|
January 1, 1987
Drug sensitivity of ten human tumor cell lines compared to mouse leukemia (L1210) cells
G J Badiner, R D Hamilton, L H Li, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1995
Synergistic and additive combinations of several antitumor drugs and other agents with the potent alkylating agent adozelesin
K S Smith, B A Folz, E G Adams, et al.
Cancer Research
|
March 1, 1976
Combination chemotherapy of L1210 leukemia with 1-beta-D-arabinofuranosylcytosine and 5-azacytidine
G L Neil, A E Berger, B K Bhuyan, et al.
The Journal of Antibiotics
|
June 1, 1977
Cytotoxicity of several marketed antibiotics on mammalian cells in culture
L H Li, S L Kuentzel, K D Shugars, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1997
Assessment of microtubule stabilizers by semiautomated in vitro microtubule protein polymerization and mitotic block assays
N M Lopes, H P Miller, N D Young, et al.
Cancer Research
|
January 1, 1988
Mutagenicity of the antitumor antibiotic CC-1065 and its analogues in mammalian (V79) cells and bacteria
P R Harbach, D M Zimmer, J H Mazurek, et al.
Page
of 8